Up next

Autoplay

IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL)

2 Views • 07/02/23
Share
Embed
administrator
administrator
Subscribers
0

In this month’s “Hot Topic,” Dr. Curt Hanson will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53 sequencing in these patients.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay